ÂÜÀòÂÒÂ×

Lynne A. Bui, MD is the Co-Founder, President, and CEO of Khloris Biosciences, Inc. She is a board-certified hematologist-oncologist, seasoned entrepreneur, angel investor, and drug developer, having unparalleled experience in basic, translational and clinical research spanning over 15 years with direct patient care and leading clinical development programs from preclinical IND enabling studies to Phase 1 to 3 registration studies for multiple approved drugs. She has held senior-level positions at Exelixis, Onyx, and Intelligence, and has experience with small molecules, antibodies, dendritic cell vaccines, gene therapies, embryonic stem cells, and cell therapies. She is also the Founder and Chairman of the Global Cancer Research Institute (GCRI) and GCRI Foundation. She received her M.D., internal medicine residency, and hematology/oncology fellowship training from the David Geffen UCLA School of Medicine, and her B.A. in molecular and cellular biology with an emphasis in neurobiology from UC Berkeley.